8 Comments
User's avatar
Julian Gillespie's avatar

thank you Dr Demasi,

.. the irony being of course, the longer the results were delayed = lives saved from those unable to receive it

will someone ever get around to explaining this to DJT?

Expand full comment
Maryanne Demasi, PhD's avatar

I know right?! I saw it reported that the delay was unethical because it was a “life saving” vaccine. 😩

Expand full comment
Jillian Stirling's avatar

That Pfizer acted in a partisan way is inexcusable. But to do so, did delay them inflicting the"Vaccine " on the world.

Expand full comment
JB watching TV's avatar

You can bet that rat fraud Fauci had his dirty mitts somewhere along this process. The pardon was pay-off!

Expand full comment
Markker's avatar

Fact that so called results were falsified but delayed makes no difference as top jobs are pre selected!

Expand full comment
Maddalena Loy's avatar

Thank you for the article. Maybe the very last word could be replaced with “political propaganda” instead of strategy? :-)

Expand full comment
Peter Engelfriet's avatar

Note that in the RKI (Robert Koch Institute) files there is a remark that EUA would have to wait until after the US elections.

Expand full comment
CMaryG's avatar
2hEdited

So Pfizer commonly adheres to secretive political manipulation.

Trump is about to expose version US

But there is an EU VERSION and Australian version - all of which led to Pfizer warlord level profiteering

Europe: with the help of ChatGPT

The European Union’s procurement of COVID-19 vaccines, particularly the substantial orders of mRNA vaccines from Pfizer-BioNTech, has been a subject of significant scrutiny and controversy. 

Massive Vaccine Orders and Resulting Waste

In May 2021, the European Commission, under President Ursula von der Leyen, secured a contract with Pfizer-BioNTech for up to 1.8 billion doses of their COVID-19 vaccine. This agreement was in addition to previous contracts, bringing the total number of doses ordered to approximately 2.6 billion. Given the EU’s population of around 450 million, this amounted to nearly six doses per person. The rationale was to ensure sufficient supply for initial vaccinations, booster shots, and to prepare for potential future variants. 

However, as vaccine uptake plateaued and the pandemic’s trajectory evolved, a significant surplus emerged. By December 2023, EU countries had discarded at least 215 million doses of COVID-19 vaccines, with an estimated cost of €4 billion to taxpayers. This figure is likely an underestimate, as some governments have been reluctant to disclose the full extent of vaccine wastage. For instance, Estonia discarded more than one dose per inhabitant, and Germany disposed of the largest volume in absolute terms. 

Transparency Concerns and ‘Pfizergate’

The procurement process’s transparency has been questioned, particularly regarding the personal involvement of President von der Leyen in negotiations with Pfizer CEO Albert Bourla. Reports indicated that von der Leyen and Bourla exchanged text messages during the negotiation phase. When journalists and transparency advocates requested access to these communications under EU freedom of information laws, the European Commission declined, stating that the messages were not archived and did not qualify as official documents.   

This refusal led to legal challenges, and in May 2025, the European Court of Justice ruled that the Commission’s decision to withhold the messages violated EU transparency laws. The court found that the Commission had failed to provide a plausible explanation for not possessing the requested documents and emphasized the importance of transparency in such significant public procurement processes.  

The controversy, dubbed ‘Pfizergate,’ has intensified scrutiny of the EU’s vaccine procurement strategy and raised questions about governance, accountability, and the balance between swift action during emergencies and adherence to transparency standards. 

Ongoing Investigations and Political Repercussions

The European Public Prosecutor’s Office (EPPO) has taken over investigations into the vaccine procurement process, examining allegations of potential misconduct, including the destruction of public documents and conflicts of interest. These investigations aim to determine whether proper procedures were followed and if any legal violations occurred during the negotiation and contracting phases. 

The outcomes of these investigations and the broader ‘Pfizergate’ controversy may have lasting implications for EU governance and public trust in institutional decision-making, especially concerning large-scale public health initiatives.

Australian version:

In the next post …

Expand full comment